Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Cookson

Showing results (61-70 of 320) with videos related to

Pageof 32
Sort By:
The Lancet. Neurology|July 10, 2003
Genes and parkinsonismJohn Hardy, Mark R Cookson, Andrew Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2020
Can Leucine-Rich Repeat Kinase 2 Inhibition Benefit GBA-Parkinson's Disease?Luis Bonet-Ponce PhD, Mark R Cookson
International Journal of Clinical and Experimental Pathology|September 12, 2008
Genetic neuropathology of Parkinson's diseaseMark R Cookson, John Hardy, Patrick A Lewis
BMC Medicine|February 25, 2012
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?Iakov N Rudenko, Ruth Chia, Mark R Cookson
Biochemical Society Transactions|March 7, 2019
LRRK2 links genetic and sporadic Parkinson's diseaseJillian H Kluss, Adamantios Mamais, Mark R Cookson
Molecular Neurodegeneration|April 7, 2019
Glial phagocytic clearance in Parkinson's diseaseMarie-Eve Tremblay, Mark R Cookson, Laura Civiero
Journal of Neurochemistry|November 1, 2016
The impact of fraudulent and irreproducible data to the translational research crisis - solutions and implementationJörg B Schulz, Mark R Cookson, Laura Hausmann
RNA Biology|December 17, 2015
ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivoAllissa A Dillman, Mark R Cookson, Dagmar Galter
The FEBS Journal|November 22, 2008
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body diseaseJose Bras, Andrew Singleton, Mark R Cookson, et al.
The Biochemical Journal|January 27, 2016
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical researchRebekah G Langston, Iakov N Rudenko, Mark R Cookson
Pageof 32

Showing results (61-70 of 320) with videos related to

Sort By:
Pageof 32
The Lancet. Neurology|July 10, 2003
Genes and parkinsonismJohn Hardy, Mark R Cookson, Andrew Singleton
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2020
Can Leucine-Rich Repeat Kinase 2 Inhibition Benefit GBA-Parkinson's Disease?Luis Bonet-Ponce PhD, Mark R Cookson
International Journal of Clinical and Experimental Pathology|September 12, 2008
Genetic neuropathology of Parkinson's diseaseMark R Cookson, John Hardy, Patrick A Lewis
BMC Medicine|February 25, 2012
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?Iakov N Rudenko, Ruth Chia, Mark R Cookson
Biochemical Society Transactions|March 7, 2019
LRRK2 links genetic and sporadic Parkinson's diseaseJillian H Kluss, Adamantios Mamais, Mark R Cookson
Molecular Neurodegeneration|April 7, 2019
Glial phagocytic clearance in Parkinson's diseaseMarie-Eve Tremblay, Mark R Cookson, Laura Civiero
Journal of Neurochemistry|November 1, 2016
The impact of fraudulent and irreproducible data to the translational research crisis - solutions and implementationJörg B Schulz, Mark R Cookson, Laura Hausmann
RNA Biology|December 17, 2015
ADAR2 affects mRNA coding sequence edits with only modest effects on gene expression or splicing in vivoAllissa A Dillman, Mark R Cookson, Dagmar Galter
The FEBS Journal|November 22, 2008
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body diseaseJose Bras, Andrew Singleton, Mark R Cookson, et al.
The Biochemical Journal|January 27, 2016
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical researchRebekah G Langston, Iakov N Rudenko, Mark R Cookson
Pageof 32